A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye

NCT05411367 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

232

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: SI-614
DRUG: Placebo

Sponsor

Seikagaku Corporation

Collaborators

[object Object]
[object Object]